Swiss National Bank Has $98.98 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Swiss National Bank reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,280,087 shares of the company's stock after selling 36,300 shares during the period. Swiss National Bank owned 0.28% of GE HealthCare Technologies worth $98,976,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. First Command Advisory Services Inc. grew its position in shares of GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company's stock valued at $25,000 after acquiring an additional 369 shares during the period. Fortitude Family Office LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $29,000. Turtle Creek Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $30,000. OFI Invest Asset Management bought a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Finally, Central Bank & Trust Co. bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $33,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on GEHC. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an "outperform" rating in a research report on Thursday, April 4th. Citigroup lifted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Mizuho reduced their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a "buy" rating for the company in a report on Wednesday. UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Finally, Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and an average price target of $95.00.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded up $1.64 during trading on Friday, reaching $79.47. The company's stock had a trading volume of 2,722,865 shares, compared to its average volume of 3,070,492. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The firm has a market capitalization of $36.27 billion, a price-to-earnings ratio of 23.24, a price-to-earnings-growth ratio of 2.86 and a beta of 1.26. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The firm has a 50 day moving average price of $88.25 and a 200 day moving average price of $79.07.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.90. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The business's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.85 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies's payout ratio is presently 3.51%.

Insider Activity

In other news, insider Frank R. Jimenez bought 1,315 shares of the company's stock in a transaction dated Wednesday, May 1st. The stock was bought at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now owns 75,796 shares of the company's stock, valued at $5,799,909.92. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company's stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.